Logo image of CATM

Cardtronics Inc (CATM) Stock Fundamental Analysis

NASDAQ:CATM - Nasdaq -

39.01  +0.03 (+0.08%)

After market: 39.01 0 (0%)

Fundamental Rating

1

Taking everything into account, CATM scores 1 out of 10 in our fundamental rating. CATM was compared to 82 industry peers in the IT Services industry. CATM has a bad profitability rating. Also its financial health evaluation is rather negative. CATM has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CATM was profitable.

1.2 Ratios

Industry RankSector Rank
ROA 1.05%
ROE 4.9%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM 5.83%
PM (TTM) 1.83%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

1

2. Health

2.1 Basic Checks

CATM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

Based on the Altman-Z score of 1.40, we must say that CATM is in the distress zone and has some risk of bankruptcy.
CATM has a Debt/Equity ratio of 1.96. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 1.96
Debt/FCF N/A
Altman-Z 1.4
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 1.02 indicates that CATM should not have too much problems paying its short term obligations.
CATM has a Quick Ratio of 1.00. This is a normal value and indicates that CATM is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.02
Quick Ratio 1

More info and screens

3

3. Growth

3.1 Past

CATM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -35.38%.
CATM shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -10.22% yearly.
The Revenue for CATM has decreased by -21.12% in the past year. This is quite bad
Measured over the past years, CATM shows a decrease in Revenue. The Revenue has been decreasing by -1.84% on average per year.
EPS 1Y (TTM)-35.38%
EPS 3Y-17.57%
EPS 5Y-10.22%
EPS Q2Q%0%
Revenue 1Y (TTM)-21.12%
Revenue growth 3Y-10.14%
Revenue growth 5Y-1.84%
Sales Q2Q%-12.64%

3.2 Future

Based on estimates for the next years, CATM will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.28% on average per year.
CATM is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.18% yearly.
EPS Next Y2.91%
EPS Next 2Y12.24%
EPS Next 3Y10.96%
EPS Next 5Y12.28%
Revenue Next Year7.38%
Revenue Next 2Y7.1%
Revenue Next 3Y6.64%
Revenue Next 5Y6.18%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CATM Yearly Revenue VS EstimatesCATM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
CATM Yearly EPS VS EstimatesCATM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 23.22, the valuation of CATM can be described as rather expensive.
Compared to an average S&P500 Price/Earnings ratio of 26.87, CATM is valued at the same level.
With a Price/Forward Earnings ratio of 18.43, CATM is valued on the expensive side.
CATM is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 35.34, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 23.22
Fwd PE 18.43
CATM Price Earnings VS Forward Price EarningsCATM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.42
CATM Per share dataCATM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CATM does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)7.98
PEG (5Y)N/A
EPS Next 2Y12.24%
EPS Next 3Y10.96%

More info and screens

0

5. Dividend

5.1 Amount

CATM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Cardtronics Inc

NASDAQ:CATM (6/18/2021, 8:00:02 PM)

After market: 39.01 0 (0%)

39.01

+0.03 (+0.08%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)N/A N/A
Earnings (Next)03-01 2022-03-01/amc
Inst Owners0%
Inst Owner Change0%
Ins Owners3.74%
Ins Owner Change0%
Market Cap1.77B
Analysts52
Price Target40.67 (4.26%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 23.22
Fwd PE 18.43
P/S 1.67
P/FCF N/A
P/OCF N/A
P/B 4.49
P/tB N/A
EV/EBITDA 9.42
EPS(TTM)1.68
EY4.31%
EPS(NY)2.12
Fwd EY5.43%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS23.3
BVpS8.69
TBVpSN/A
PEG (NY)7.98
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.05%
ROE 4.9%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 5.83%
PM (TTM) 1.83%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 1.96
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.02
Quick Ratio 1
Altman-Z 1.4
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-35.38%
EPS 3Y-17.57%
EPS 5Y-10.22%
EPS Q2Q%0%
EPS Next Y2.91%
EPS Next 2Y12.24%
EPS Next 3Y10.96%
EPS Next 5Y12.28%
Revenue 1Y (TTM)-21.12%
Revenue growth 3Y-10.14%
Revenue growth 5Y-1.84%
Sales Q2Q%-12.64%
Revenue Next Year7.38%
Revenue Next 2Y7.1%
Revenue Next 3Y6.64%
Revenue Next 5Y6.18%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A